中国医药商业 物流 专项研究报告 (2003 版 )

Embed Size (px)

DESCRIPTION

中国医药商业 物流 专项研究报告 (2003 版 ). 北京秦脉医药咨询有限责任公司 编制. 概述 中国医药商业历史回顾 中国医药流通市场现状描述 医院市场 商业市场 零售市场 农村市场 多种医药物流模式分析 国内医药物流中心建设情况 成都模式 上海医药模式 九州通模式 阜阳太和模式 三九模式 双鹤模式 医药商业的机会与挑战 销售上升利润剧降的压力与出路 加入 WTO 与提升国际竞争力 政策导向与 GSP 认证 风起云涌的购并 , 重组与联合. 西方医药物流经验参考 西方发达国家现代物流的特点 美国医药物流模式 香港 裕利物流模式 - PowerPoint PPT Presentation

Citation preview

  • (2003)

  • WTOGSP,GSP

  • ,?12.6%,1%,,,??,,,,?,,,???

  • 1984 4 10003000 ,,,,,,

  • 8599, ,,,,3 , ,

  • ,,,,,,,, ,

  • 2002776232 2002573 IMS11%,19994262002573,57.6%

  • ,,19994272002573,200364611%,20012003,20002002*20032002Q3-2003Q2

  • 0257332.7%,,57.6%

  • 2002,1999,,

  • ( ),80%,,,,,

  • 0202

  • ,60006300162000400 1020%20021300411

  • 2107,34% 1587,1%,9.35,40%021712.56%,

  • 02

  • 10101119,70%, 5100,,,,,,,,8%,,,,10%,12.38%

    No. ) %%No. ) %%1185.17812.3814.0440992696.54810.759.85-81742180.4807.028.1227421776.1195.424.67-43153156.6497.648.6323301859.9208.537.23-51094123.35610.8911.9914983959.8269.978.57-78415122.58210.7811.61161521058.3326.377.4611195

  • 1022%10350,23%,,,,,,,107,8000

    No. ) %%No. ) %%1153.112.98.399.782001630.215.112.6110.92-54911250.220.69.619.5956911728.822.612.4711.47-281344.844.18.756.71-79351827.113.38.958.52-17271438.931.57.178.01-34091922.914.314.714.86-3671530.413.014.710.1-12862022.83.510.7112.752542

  • 1010103,7%,,,,,20,,15%,29%

    No. ) %%No. ) %%121.57.811.4712.321900612.27.414.1112.23-2211220.911.216.2619.156575.18.02924.72-2561320.717.015.7313.65-161883.48.613.4711.91-490416.023.015.5217146192.93.216.3617.51467512.522.316.1615.58-495102.42.719.4114.05-242

  • 637,40%,6.7,,7,,1,, (),

    No. ())02()1(,,,,)637250.9667872(,,,)284119.2301633(,,,,)234152.059054(,,,)18098.923105(,,)7783.4-100486(,,,,)10655.42477(,,,,)6634.4-1813

  • 10426,22%,510

    No. )No. 11207570127235692345472834308894453021005627789567255821782532338924347291023034310

  • ,,

    ,2002,100,72 ,,,,

  • ,

  • ,12196,41,2002,509728,142,,200250%:

  • ,,3105048.6%7.501,2010060%,2 1062%

  • WTO,,,,

  • ,45,,,,,, ,

  • ,,,,, ,

  • ,,

    024.8,75103,80%,129

  • ,., ,,, ,,,,:,,

  • ,SFDA

  • ,,,,,,,,,,,

  • ,,, ,11%,56%

  • 10,,

  • ,,, ,,,, , ,, ,,, , , ,,

  • -02

  • 01 ,,,,, 1000,10,7 ,,,,, ,

  • ,,

  • -- 220,500003GSP5 12000,2,110,,10 ,,,,,,,, 0320,055005,,

  • 26,5,800,,,,35,,,,04

  • 200,5,4 0410, 803, 30024300

  • GSP,40,1.5,,2000,48,200024 ,0310 150, 031000,1000

  • ,,,5,114,1.91,10,,12, 24

  • 02021065540450,,

  • 5,2002,72,2.12005150, 2010400500 860,,

    ,,

  • ,,, 1.7,80,2.522,80,9,,WMS ,,,

  • ,,, ,,,,, ,,

  • , 0220, 01GSP,,1.8 80001/3,2/3

    ,,,,

  • , 15201000, 6,,,, ,

  • ,,,, , 7,,,,,,,600235,70,10,4%

    ,, ,,

  • BPR

  • ,,,,,

    ,,,,,,

  • ,

  • 890, .,,, ,,,

    ,),,,,,,,

  • 11,, ,,, ,,5%,,

  • --,:1000,2000,900,,

  • 1600,5830000,6000,200,,, 5-6,4000,025,200,500,12%10/,2% 800,, 2,3,,, 1000,1/3, ,,,

  • ,,,,,,,,,,,,,,,, 18000,,1 1000, 30,,200 ,

  • 39,:? ,,02,,,,,,,

  • ,, , ,,,,,,,,,

    , ,,,,,,,

  • ,,,,,,,,,,,,,,,,,,,,,,,,,,,(),,,

  • WTOGSP,

  • GSPGSPGSP,GSP GSP 4,12.56% , ,,,

  • ,,,

  • GSP 510504020

    ,,,,GSP,,

  • WTO WTO200311 12%5.5%-6.5%,,

  • ,,, 1.2,5149,30,

  • ,,,11,40%,, ,10.27 ,51%,,49%

  • ,WTO ,,,,,,GSP,,,,,,,,,,

  • ,

  • ,,,,,

    iteaidWallgreenCVS,.MckessonCardinal Health,85%4%,3%!!!

  • ,, ,,,,,,,,,, , Walgreen,,,,,, ,1.,.,.,,,

  • ,,,,,,--

  • ,,,, ,,, ,, ,,,, ,,

    ,,

  • ,,,,, ,,

  • GDP20%30~40%109020004GDP50% GDP10% 10%330

  • ,,,,, ,,,,,,,,

  • GSP

  • 90GDP,GDP19914.11%20015.37%,0163SARS, ,,,,,,

  • GSP GSPGSPGSP2004,GSP,GSP110GSP,, ,,,

  • , 20029,8000,50,,,,

  • ,,10/200323 2010 3

  • ,,,, ,2001,,, (2002)705030%50%,70%

  • ,,,,,

  • 510504020 025810 02200652 11

  • ()

  • ,,,,,,,,,WTO,,,,,

  • ,

  • ,,,

  • ,800,,,

  • ,,,,,,,

  • ,

  • , GSP

    ,,, ,

  • ,, ,,,,,,,,

  • ,, ,,

  • ,,,,, IT,,,,,,, ,

  • , 7130,,,,,,GSP,, ,,,

  • ,, ,,

  • ,,,,,,?

  • 200312